METNZ Stock Overview
Through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Metall Zug AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 1,120.00 |
| 52 Week High | CHF 1,545.00 |
| 52 Week Low | CHF 1,120.00 |
| Beta | 0.98 |
| 11 Month Change | -7.05% |
| 3 Month Change | -10.40% |
| 1 Year Change | -19.13% |
| 33 Year Change | -43.29% |
| 5 Year Change | n/a |
| Change since IPO | -48.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| METNZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -2.2% | -0.2% | 1.7% |
| 1Y | -19.1% | -2.3% | 8.3% |
Return vs Industry: METNZ underperformed the UK Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: METNZ underperformed the UK Market which returned 8.3% over the past year.
Price Volatility
| METNZ volatility | |
|---|---|
| METNZ Average Weekly Movement | 2.3% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: METNZ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: METNZ's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 990 | Matthias Rey | www.metallzug.ch |
Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally. The company offers medical and surgical instrument sterilization, disinfection, and cleaning product and service solutions. It also develops, produces, and distributes devices and solutions for medical diagnosis, microsurgery, and eye care specialist; and offers diagnostics equipment, such as slit lamps, perimetry, and biometry for cataract diagnosis and treatment; equipment for ophthalmologists, including stands, chairs, industrial high-precision surgical microscopes, and other accessories; and augmented reality technology and digital imaging for the eye care specialists.
Metall Zug AG Fundamentals Summary
| METNZ fundamental statistics | |
|---|---|
| Market cap | CHF 468.00m |
| Earnings (TTM) | CHF 68.51m |
| Revenue (TTM) | CHF 447.48m |
6.8x
P/E Ratio1.0x
P/S RatioIs METNZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| METNZ income statement (TTM) | |
|---|---|
| Revenue | CHF 447.48m |
| Cost of Revenue | CHF 314.05m |
| Gross Profit | CHF 133.43m |
| Other Expenses | CHF 64.93m |
| Earnings | CHF 68.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 24, 2025
| Earnings per share (EPS) | 152.23 |
| Gross Margin | 29.82% |
| Net Profit Margin | 15.31% |
| Debt/Equity Ratio | 8.9% |
How did METNZ perform over the long term?
See historical performance and comparison